Cargando…

Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39)

INTRODUCTION: Diagnosis and management of Parkinson's disease (PD) rely heavily on evaluation of clinical symptoms and patients' subjective perception of their condition. The purpose of this study was to evaluate the validity, acceptability, and reliability of the Estonian version of the 3...

Descripción completa

Detalles Bibliográficos
Autores principales: Krikmann, Ülle, Taba, Pille, Lai, Taavi, Asser, Toomas
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2335093/
https://www.ncbi.nlm.nih.gov/pubmed/18364047
http://dx.doi.org/10.1186/1477-7525-6-23
_version_ 1782152806353862656
author Krikmann, Ülle
Taba, Pille
Lai, Taavi
Asser, Toomas
author_facet Krikmann, Ülle
Taba, Pille
Lai, Taavi
Asser, Toomas
author_sort Krikmann, Ülle
collection PubMed
description INTRODUCTION: Diagnosis and management of Parkinson's disease (PD) rely heavily on evaluation of clinical symptoms and patients' subjective perception of their condition. The purpose of this study was to evaluate the validity, acceptability, and reliability of the Estonian version of the 39-question Parkinson 's disease Questionnaire (PDQ-39). METHODS: Study subjects were approached during their regular clinic follow-up visits. 104 patients consented to the study and 81 completed questionnaires were used for subsequent testing of psychometric characteristics, validity and reliability. RESULTS: The content validity was assessed through qualitative content analysis during the pilot study. The patients indicated that the questions were relevant to measure the quality of life of people with PD. The analysis of means showed that the ceiling and floor effects of domain results were within the limits of 15% of Summary Index and of all domains except Stigma, Social Support and Communication where the ceiling effect was 16% to 24% of the responses. Convergent validity was interpreted through correlation between disease severity and PDQ-39 domains. There was a statistically significant difference between the domain scores in patients with mild versus moderate PD in domains of Mobility, ADL, and Communication but not for Stigma, Social Support and Cognition. The reliability was good, Cronbach alpha for all domains and summary index was over 0.8 and item-test correlations between domains and summary index ranged from 0.56 to 0.83. CONCLUSION: The psychometric characteristics of an Estonian version of the PDQ-39 were satisfactory. The results of this study were comparable to the results of previous validation studies in other cultural settings in UK, USA, Canada, Spain and Italy. The Estonian version of the PDQ-39 is an acceptable, valid and reliable instrument for quality of life measurement in PD patients.
format Text
id pubmed-2335093
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-23350932008-04-25 Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39) Krikmann, Ülle Taba, Pille Lai, Taavi Asser, Toomas Health Qual Life Outcomes Research INTRODUCTION: Diagnosis and management of Parkinson's disease (PD) rely heavily on evaluation of clinical symptoms and patients' subjective perception of their condition. The purpose of this study was to evaluate the validity, acceptability, and reliability of the Estonian version of the 39-question Parkinson 's disease Questionnaire (PDQ-39). METHODS: Study subjects were approached during their regular clinic follow-up visits. 104 patients consented to the study and 81 completed questionnaires were used for subsequent testing of psychometric characteristics, validity and reliability. RESULTS: The content validity was assessed through qualitative content analysis during the pilot study. The patients indicated that the questions were relevant to measure the quality of life of people with PD. The analysis of means showed that the ceiling and floor effects of domain results were within the limits of 15% of Summary Index and of all domains except Stigma, Social Support and Communication where the ceiling effect was 16% to 24% of the responses. Convergent validity was interpreted through correlation between disease severity and PDQ-39 domains. There was a statistically significant difference between the domain scores in patients with mild versus moderate PD in domains of Mobility, ADL, and Communication but not for Stigma, Social Support and Cognition. The reliability was good, Cronbach alpha for all domains and summary index was over 0.8 and item-test correlations between domains and summary index ranged from 0.56 to 0.83. CONCLUSION: The psychometric characteristics of an Estonian version of the PDQ-39 were satisfactory. The results of this study were comparable to the results of previous validation studies in other cultural settings in UK, USA, Canada, Spain and Italy. The Estonian version of the PDQ-39 is an acceptable, valid and reliable instrument for quality of life measurement in PD patients. BioMed Central 2008-03-25 /pmc/articles/PMC2335093/ /pubmed/18364047 http://dx.doi.org/10.1186/1477-7525-6-23 Text en Copyright © 2008 Krikmann et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Krikmann, Ülle
Taba, Pille
Lai, Taavi
Asser, Toomas
Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39)
title Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39)
title_full Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39)
title_fullStr Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39)
title_full_unstemmed Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39)
title_short Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39)
title_sort validation of an estonian version of the parkinson's disease questionnaire (pdq-39)
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2335093/
https://www.ncbi.nlm.nih.gov/pubmed/18364047
http://dx.doi.org/10.1186/1477-7525-6-23
work_keys_str_mv AT krikmannulle validationofanestonianversionoftheparkinsonsdiseasequestionnairepdq39
AT tabapille validationofanestonianversionoftheparkinsonsdiseasequestionnairepdq39
AT laitaavi validationofanestonianversionoftheparkinsonsdiseasequestionnairepdq39
AT assertoomas validationofanestonianversionoftheparkinsonsdiseasequestionnairepdq39